Related Experiment Video
Updated: Oct 23, 2025

08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
18.4K
A genotype-phenotype screening system using conditionally immortalized immature dendritic cells.
Liwei Zhao1,2, Peng Liu1,2, Wei Xie1,2,3
1Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France.
STAR Protocols
|August 25, 2021
Summary
This study presents a new CRISPR/Cas9 gene knockout protocol for dendritic cells (DCs). This method enables comprehensive genetic screening of DC functions and their role in anticancer immunity.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Dendritic cells (DCs) are crucial for immune responses.
- Genetic manipulation of DCs is essential for understanding their functions.
- Existing methods for DC genetic studies have limitations.
Purpose of the Study:
- To establish a protocol for CRISPR/Cas9-mediated gene knockout in immortalized immature dendritic cells (DCs).
- To enable large-scale genetic screening of DC functions in vitro and in vivo.
- To link DC genotype to phenotype for a deeper understanding of their roles.
Main Methods:
- CRISPR/Cas9 gene editing technology.
- Use of conditionally immortalized immature dendritic cells (DCs) for limitless expansion.
- In vitro assays for phagocytosis, cytokine production, co-stimulatory/co-inhibitory molecule expression, and antigen presentation.
- In vivo evaluation of anticancer immune responses.
Main Results:
- A robust protocol for gene knockout in immortalized immature DCs was developed.
- The protocol facilitates comprehensive functional screening of DCs.
- The method allows for the direct correlation of DC genotype with observed phenotypes.
Conclusions:
- This protocol significantly advances the genetic study of dendritic cells.
- It provides a powerful tool for investigating DC biology and their role in immunity.
- The described methods are valuable for researchers studying DC-mediated anticancer immune responses.

